119th Congress
S. 1302
Increasing Transparency in Generic Drug Applications Act
- Introduced
- In committee
- Passed Senate
- Passed House
- To President
- Became law
- Sponsor
- Margaret Wood Hassan(D-NH)
- Introduced
- Apr 3, 2025
- Policy area
- Health
- Committees
- Senate Committee on Health, Education, Labor, and Pensions
- Official text
- Introduced in Senate · Congress.gov page
Cosponsors (6)
Original cosponsors (3)
- John W. Hickenlooper (D-CO)
- Mike Lee (R-UT)
- Rand Paul (R-KY)
Added later (3)
- James Lankford (R-OK) · May 8, 2025
- Jon Husted (R-OH) · Dec 9, 2025
- Jon Ossoff (D-GA) · Dec 9, 2025
Summary
No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.
Official title: A bill to provide for increased transparency in generic drug applications.
Latest action(Apr 3, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Roll-call votes
No recorded votes on this bill.
Actions
- Apr 3, 2025 · Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. - Apr 3, 2025
Introduced in Senate